In vitro analysis of germ cell genotoxicity in testis explant cultures: spermatid micronucleus assays.
Explant cultures of testes from the frog Xenopus laevis have been employed to evaluate the application of testis culture to the routine screening of potential germ cell genotoxicants. Testis explants were incubated with varied concentrations of 3 model mutagens (9,10-dimethyl-1,2-benzanthracene, cyclophosphamide, adriamycin) and solvent controls. Round spermatids were isolated from testes cultured 2-30 days after exposure to each mutagen. The spermatids were then stained with Hoechst 33258 and spermatid micronuclei were scored with a fluorescence microscope. Acute exposure of testes to each mutagen resulted in a dose-dependent increase in spermatid micronuclei that was stage specific and proportional to the length of the exposure period. The assay sensitively detected clastogenic effects by 10(-7) M adriamycin (4-h exposure period) and 10(-6) M cyclophosphamide and dimethylbenzanthracene (24-h exposure). The results demonstrate the feasibility of in vitro approaches to the routine screening and investigation of genotoxicity in the premeiotic S through meiotic division stages of vertebrate spermatogenesis.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000494:pharmacology; D002453:Cell Cycle / Q000187:drug effects; D002869:Chromosome Aberrations; D003520:Cyclophosphamide / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D008297:Male; D009152:Mutagenicity Tests / Q000379:methods*; D009924:Organ Culture Techniques; D013087:Spermatids / Q000648:ultrastructure*; D013091:Spermatogenesis / Q000187:drug effects*; D013737:Testis / Q000187:drug effects*
D015127:9,10-Dimethyl-1,2-benzanthracene; D004317:Doxorubicin; D003520:Cyclophosphamide